Clinical Trial Update: Study to Evaluate the Efficacy and Safety of GX-E2 in the Anemic Patients Diagnosed With Chronic Kidney Disease (CKD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of GX-E2 in anemic patients with chronic kidney disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• GX-E2

Snippet

Sponsor: Genexine, Inc. | Conditions: Anemia, Chronic Kidney Disease | Phase 2 | Status: COMPLETED